Detalles de la búsqueda
1.
Theoretical, in Vitro Antiproliferative, and in Silico Molecular Docking and Pharmacokinetics Studies of Heteroleptic Nickel(II) and Copper(II) Complexes of Thiosemicarbazone-Based Ligands and Pefloxacin.
Chem Biodivers
; 20(9): e202300702, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528701
2.
Synthesis of Palladium(II) Complexes via Michael Addition: Antiproliferative Effects through ROS-Mediated Mitochondrial Apoptosis and Docking with SARS-CoV-2.
Inorg Chem
; 59(23): 17109-17122, 2020 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33231439
3.
Biocompatibility, in Vitro Antiproliferative, and in Silico EGFR/VEGFR2 Studies of Heteroleptic Metal(II) Complexes of Thiosemicarbazones and Naproxen.
Chem Res Toxicol
; 32(8): 1554-1571, 2019 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31241919
4.
DNA profiling and in vitro cytotoxicity studies of tetrazolo[1,5-a]pyrimidine-based copper(II) complexes.
Biometals
; 32(4): 611-626, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31098735
5.
In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2â³-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
J Biol Inorg Chem
; 22(7): 1109-1122, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28884428
6.
In vitro anti-proliferative, and in silico ribonucleotide reductase and pharmacokinetics studies of heteroleptic silver(I), nickel(II) and copper(II) complexes of 4-methyl-3-thiosemicarbazones and ibuprofen.
J Trace Elem Med Biol
; 79: 127211, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37263062
7.
Silver(I) metallodrugs of thiosemicarbazones and naproxen: biocompatibility, in vitro anti-proliferative activity and in silico interaction studies with EGFR, VEGFR2 and LOX receptors.
Toxicol Res (Camb)
; 9(1): 28-44, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32440336
8.
Exploring the DNA interactions, FGF growth receptor interaction and biological screening of metal(II) complexes of NNN donor ligand derived from 2(aminomethyl)benzimidazole.
Int J Biol Macromol
; 126: 1303-1317, 2019 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244126
9.
Copper complexes as prospective anticancer agents: in vitro and in vivo evaluation, selective targeting of cancer cells by DNA damage and S phase arrest.
RSC Adv
; 8(30): 16973-16990, 2018 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35540520
10.
Heteroleptic silver(I) complexes with 2,2':6',2â³-terpyridines and naproxen: DNA interaction, EGFR/VEGFR2 kinase, growth inhibition and cell cycle arrest studies.
Mater Sci Eng C Mater Biol Appl
; 76: 601-615, 2017 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28482570
11.
Theoretical calculations, DNA interaction, topoisomerase I and phosphatidylinositol-3-kinase studies of water soluble mixed-ligand nickel(II) complexes.
Chem Biol Interact
; 248: 21-35, 2016 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26874211
12.
Corrigendum to "Heteroleptic silver(I) complexes with 2,2':6',2â³-terpyridines and naproxen: DNA interaction, EGFR/VEGFR2 kinase, growth inhibition and cell cycle arrest studies" [Mater. Sci. Eng. C 76 (2017) 601-615].
Mater Sci Eng C Mater Biol Appl
; 122: 111818, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641883
13.
Targeting of DNA molecules, BSA/c-Met tyrosine kinase receptors and anti-proliferative activity of bis(terpyridine)copper(ii) complexes.
Dalton Trans
; 45(18): 7794-814, 2016 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27063595
Resultados
1 -
13
de 13
1
Próxima >
>>